1dva: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1dva" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dva, resolution 3.00Å" /> '''CRYSTAL STRUCTURE O...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1dva.gif|left|200px]]<br />
[[Image:1dva.gif|left|200px]]<br /><applet load="1dva" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1dva" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1dva, resolution 3.00&Aring;" />
caption="1dva, resolution 3.00&Aring;" />
'''CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA'''<br />
'''CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA'''<br />


==Overview==
==Overview==
Potent anticoagulants have been derived by targeting the tissue, factor-factor VIIa complex with naive peptide libraries displayed on M13, phage. The peptides specifically block the activation of factor X with a, median inhibitory concentration of 1 nM and selectively inhibit, tissue-factor-dependent clotting. The peptides do not bind to the active, site of factor VIIa; rather, they work by binding to an exosite on the, factor VIIa protease domain, and non-competitively inhibit activation of, factor X and amidolytic activity. One such peptide (E-76) has a well, defined structure in solution determined by NMR spectroscopy that is, similar to the X-ray crystal structure when complexed with factor VIIa., These structural and functional studies indicate an allosteric 'switch', mechanism of inhibition involving an activation loop of factor VIIa and, represent a new framework for developing inhibitors of serine proteases.
Potent anticoagulants have been derived by targeting the tissue factor-factor VIIa complex with naive peptide libraries displayed on M13 phage. The peptides specifically block the activation of factor X with a median inhibitory concentration of 1 nM and selectively inhibit tissue-factor-dependent clotting. The peptides do not bind to the active site of factor VIIa; rather, they work by binding to an exosite on the factor VIIa protease domain, and non-competitively inhibit activation of factor X and amidolytic activity. One such peptide (E-76) has a well defined structure in solution determined by NMR spectroscopy that is similar to the X-ray crystal structure when complexed with factor VIIa. These structural and functional studies indicate an allosteric 'switch' mechanism of inhibition involving an activation loop of factor VIIa and represent a new framework for developing inhibitors of serine proteases.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1DVA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GLC, FUC, FUL, CA, CAC, ACE and CH2 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DVA OCA].  
1DVA is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GLC:'>GLC</scene>, <scene name='pdbligand=FUC:'>FUC</scene>, <scene name='pdbligand=FUL:'>FUL</scene>, <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=CAC:'>CAC</scene>, <scene name='pdbligand=ACE:'>ACE</scene> and <scene name='pdbligand=CH2:'>CH2</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DVA OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Eigenbrot, C.]]
[[Category: Eigenbrot, C.]]
[[Category: Ultsch, M.H.]]
[[Category: Ultsch, M H.]]
[[Category: ACE]]
[[Category: ACE]]
[[Category: CA]]
[[Category: CA]]
Line 29: Line 28:
[[Category: protein-peptide complex]]
[[Category: protein-peptide complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:36:19 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:20:50 2008''